We investigated whether alteration of extracellular and intracellular Ca 2+ concentrations, protein kinase C, and calmodulin modulate norepinephrine(NE)-induced inositol 1,4,5-trisphosphate (IP 3 ) formation in neonatal rat atrial myocytes. NE-induced IP 3 production in atrial myocytes was stimulated by elevation of extracellular Ca 2+ in a dosedependent manner. However, TMB-8 (an intracellular calcium antagonist) and A23187 (an intracellular calcium agonist) did not significantly affect NE-induced IP 3 production. PMA (a protein kinase C agonist) significantly decreased and staurosporine (a protein kinase C antagonist) significantly stimulated NE-induced IP 3 production. W7 (a calmodulin antagonist) significantly increased the NE-induced IP 3 . In conclusion, elevation of extracellular Ca 2+ concentrations affects NE-induced IP 3 formation in atrial myocytes. Protein kinase C and calmodulin may control the IP 3 response to NE by a negative feedback mechanism. ( 2) The signal transduction of NE occurs through activation of phospholipase C (PLC), which leads to release of IP 3 . On the other hand, release of IP 3 by NE in atrial cells is also associated with the development of arrhythmias.
NE activates PLC and stimulates the rapid formation of IP 3 and diacylglycerol (DAG). IP 3 stimulates the release of Ca 2+ from sarcoplasmic reticulum. The intracellular calcium binds to calmodulin. The calcium-calmodulin complex activates Ca 2+ /CaM-dependent protein kinase and contributes to phosphorylation of myosin light chain. DAG produces protein kinase C (PKC), which also plays an important role in phosphorylation of myosin light chain. 4) Activation of PKC, increases in extracellular and intracellular Ca 2+ , and calmodulin each enhances ANP secretion by α1-adrenoceptor stimulation. 1) Increases in intracellular and extracellular Ca 2+ , PKC, and calmodulin have a significant role in arrhythmias. 5) In this study, we investigated the effect of alteration of extracellular and intracellular Ca 2+ , PKC, and calmodulin on NE-induced IP 3 formation in neonatal rat atrial myocytes.
METHODS
Isolation of cardiomyocytes from neonatal rat heart: The research was conducted according to the Helsinki Declaration and approved by our animal use committee. Three-day-old neonatal rats were anesthetized with sevoflurane and killed by cervical dislocation. Myocytes were isolated using an aseptic technique. The hearts were rapidly removed and placed in ice-cold Ca 2+ -and Mg
2+
-free PBS containing 40 U mL -1 sodium heparin, 4 mM glucose, and 25 mM HEPES. The hearts were washed with 4 liters of PBS. The atria and ventricles were divided and kept in icecold MEM and PBS, respectively. The atria were minced with scissors into 1 to 3 mm 3 fragments, which were then washed with PBS by gently stirring in a 37 °C water-jacketed Erlenmeyer flask for 10 minutes. The tissue was then enzymatically digested five times for 10 minutes each with 10 mL PBS containing 0.1% trypsin, 0.1% collagenase (type 5), 15 g mL -1 deoxyribonuclease 1, and 1% chicken serum. The liberated cells were collected by centrifugation at 200 × g and resuspended in PBS. The pooled and washed cells were plated in T-75 cell culture flasks in minimal essential medium (containing Hank's salts, L-glutamine, 5% chicken serum, 3 mM pyruvic acid, MEN vitamins, 1 g mL -1 insulin, 1 g mL -1 transferrin, 10 ng mL -1 selenium, and 50 g mL -1 gentamicin). The nonadherent cells were harvested after incubation at 37°C for 60 minutes in a humidified incubator with 5% CO 2 in air. The cells were counted and resuspended in minimal essential medium containing 0.1 mM 5-bromo-2'deoxyuridine to inhibit cell division and thereby control nonmyocyte cell growth. Fibroblasts were separated from cardiomyocytes. The suspension was then transferred to 0.1% gelatincoated 25 cm 2 flasks for measurement of IP 3 . The culture medium was changed after 48 hours to the above media and finally to serum-free medium 24 hours before the cells were studied. After four days, the cells were used at confluence Vol 44 No 4 for this study to provide stable data. A highly enriched population of myocardiocytes was identified by light microscope examination and the cultures could be maintained for at least 14 days with little change in overall cell morphology. IP 3 measurement: Twenty-four hours before the experiments, the culture medium was changed to calcium free minimal essential medium. After NE was added for 20 seconds, the reaction was stopped by addition of 5 mL ice-cold 1 M trichloroacetic acid (TCA) for each 1 mg of cells. The acid extract was homogenized and centrifuged at 0-4°C for 10 minutes at 1000 × g. TCA was removed from the extracts by adding 2 mL of a mixture of 3 vol of 1,1,2-trichloro-1,2,2-trifluoroethane plus 1 vol of trioctylamine for each mL of TCA extract. IP 3 content in the aqueous top layer was determined by means of a radioreceptor assay kit (NEN Research Products, Boston, USA).
The cultures were incubated at extracellular Ca 2+ concentrations of 0, 0.25, 0.5, 1, and 5 mM for 60 minutes before adding NE. Cells were treated with phorbol 12 myristate 13 acetate (PMA)(a PKC agonist) for 10 minutes, and staurosporine (a PKC antagonist), 8-(N,N diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8) (an intracellular calcium antagonist), A23187 (an intracellular calcium agonist), and N-(6-aminohexyl)-5-chloro-naphthalenesulphonamide (W7) (a calmodulin antagonist) for 30 minutes before exposure to NE. The PMA, staurosporine, and W7 experiments were conducted in the presence of 0.5 µM of extracellular calcium. Protein measurements: Protein was determined by the method of Bradford using bovine serum albumin as standard. 6) Measurement of intracellular calcium mobilization: To evaluate whether TMB-8 and A23187 cause mobilization of intracellular calcium, we used the fluorescent calcium indicator chlortetracycline. Cell suspensions were incubated with 10 µM chlortetracycline for two hours at 25°C. Four samples were withdrawn one minute after the addition of NE. TMB-8 or A23187 was added 15 minutes before the addition of NE. The samples were placed into plastic conical centrifuge tubes and centrifuged at 7000 × g for one minute. Immediately after centrifugation, the supernatant was aspirated, leaving the undisturbed pellets in the tube tips. The tube tips were removed with a hot surgical blade and placed in acrylic holders for fluorescence determination with a photon-counting microspectrofluorometer. Protein kinase C assay: Cardiomyocytes were exposed to NE, PMA, or staurosporine for the indicated times. Cells were then homogenized in buffer containing 20 mM Hepes, 5 mM EGTA, 0.25 mM sucrose, 5 mM DTT, 1 g L -1 BSA, and 50
µg mL -1 leupeptin by sonication (five times for 10 seconds) followed by 9 × 4 strokes in a glass potter homogenizer. The whole homogenate was considered as the cytosolic fraction. The pellet was solubilized in homogenizing buffer containing 0.4 % Triton X-100 and centrifuged at 10,000 × g for 10 minutes. Both frac-tions were then applied to DEAE-cellulose columns, which were washed with 2.5 mL of a buffer containing 20 mM Tris-HCl (pH 7.4), 2 mM EDTA, 5 mM EGTA, and 2 mM PMSF. PKC was eluted with the same buffer containing 100 mM NaCl. PKC activity was then determined by measuring the Ca 2+ and phospholipid-dependent transfer of 32 P from [ 32 P]ATP to histone III-S. One hundred µL of the eluate was added to 150 µL of a solution containing 20 mM Tris-HCl (pH 7.5), 10 mM magnesium acetate, 25 µg histone III-S either in the absence or presence of 0.75 mM CaCl 2 , 12 µg of phosphatidylserine, and 1.6 µg of 1,2-diolein. The reaction was started by addition of 50 µM ATP containing 5 µCi of by liquid scintillation. Translocation of PKC was determined by measuring the ratio of membrane associated activity/total activity (total activity is cytosolic activity plus particulate activity). Measurement of ANP secretion: Twenty-four hours before the experiments, the culture medium was changed to serum-free minimal essential medium. Cardiomyocytes were exposed to 1 µM NE, 0.25, 0.5, 1, and 5 µM extracellular calcium, 10 µM A23187, and 10 nM PMA or 1 µM W7 for the indicated times at 37°C in 5% CO 2 , after which the entire supernatant was collected. ANP was measured by radioimmunoassay (RIA)(Eiken, Tokyo). The mean intra-assay and interassay CV were 10.5 % and 12.5 %, respectively. Solutions and drugs: Norepinephrine, ANP, the stable analog of TMB-8, A23187, PMA, staurosporine, and W7 were purchased from Sigma Chemical Co. (St Louis, USA). A radioreceptor assay kit for measurement of IP 3 was purchased from NEN Research Products (Boston, USA). PMA and staurosporine were dissolved in 0.1% dimethyl sulfoxide. Statistical analysis: The data are expressed as the mean ± standard error of the mean. Each experiment was carried out in duplicate. Every experiment was repeated six times with different cell preparations unless otherwise specified. Statistical comparisons were made using ANOVA for repeated measures and the Student-Newman-Keuls multiple comparison test. Differences in mean values were considered significant at P < 0.05.
RESULTS
Exposure to 100 nM, 1, 10, and 100 µM of NE increased IP 3 production from a basal level of 106.5 ± 9.1 to 272.2 ± 23.1, 344.7 ± 19.4, 416.0 ± 24.8, and 474.0 ± 34.8 pmol mg protein -1 , respectively (P < 0.001). To study the effect of PKC on NE-induced IP 3 production, we studied the effects of PMA (a PKC agonist) and staurosporine (a PKC antagonist) on NEinduced IP 3 production. PMA alone or staurosporine alone had no effect on IP 3 production. The ratio of membrane activity/cytosolic activity plus membrane activity changed from 0.38 ± 0.04 of control to 0.77 ± 0.09 after 10 nM PMA Figure 1 . Effect of extracellular calcium on NE-induced IP 3 production. Cardiomyocytes were incubated for 60 minutes at 37°C in the presence of extracellular calcium (0, 0.25, 0.5, 1 and 5 mM). IP 3 production was measured after NE (1 µM) stimulation for 20 seconds as described in the Methods. Data are mean ± SEM. n = 6. *:P < 0.05, **: P < 0.01, ***: P < 0.001 vs NE-induced IP 3 production in absence of extracellular calcium. #:P < 0.05, vs basal. administration, 0.27 ± 0.02 after 10 nM staurosporine administration, and 0.54 ± (Figure 2) .
We studied the effect of W7, a calmodulin antagonist, on NE-induced IP 3 production. One µM W7 alone had no effect on IP 3 production. One hundred nM and 1 µM W7 significantly increased NE-induced IP 3 from 344.7 ± 13.0 to 410.3 ± 19.3 (P < 0.05) and 523.5 ± 34.7 (P < 0.01) pmol mg protein -1 . ANP secretion from atrial cells increased from 0.63±0.6 pmol mL -1 of control to 5.22 ± 0.75 pmol mL -1 after administration of 1 µM NE, 2.58 ± 0.31 pmol mL -1 after administration of 0.5 µM extracellular calcium, 2.01 ± 0.64 pmol mL-1 after administration of 10 µM A23187, 3.60 ± 0.38 pmol mL -1 after administration of 10 nM PMA or 2.37 ± 0.39 pmol mL -1 after administration of 1 µM W7. Effect of phorbol 12 myristate 13 acetate (PMA)(a PKC agonist) and staurosporine (a PKC antagonist) on NEinduced IP 3 production. The cultures were incubated at 37°C in the presence of 1 and 10 nM PMA for 30 minutes and 1 and 10 nM staurosporin for 30 minutes. IP 3 production was measured after NE (1 µM) stimulation for 20 seconds as described in the Methods. The concentration of extracellular calcium in the culture was 0.5 µM. Data are mean ± SEM. n = 6. *: P < 0.05, **: P < 0.01, ***: P < 0.001, vs NE-induced IP 3 production. ###: P < 0.001, vs Basal.
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DISCUSSION
We found that NE-induced IP 3 production in atrial myocytes was stimulated by extracellular Ca 2+ in a dose-dependent manner. G-protein activated by extracellular Ca 2+ stimulates PLC to activate mobilization of intracellular Ca 2+ stores and stimulate Ca 2+ entry across the plasma membrane depending on phosphoinositide turnover.
7) Extracellular Ca 2+ is reported to activate G-protein via calcium ion sensing receptors. 8) NE increased the intracellular Ca 2+ concentration. The increase appears to be due to both activation of mobilization of intracellular Ca 2+ stores and stimulation of Ca 2+ entry across the plasma membrane. Thus, IP 3 production stimulated by extracellular Ca 2+ appears to be associated with calcium ion sensing receptors. TMB-8 (an intracellular calcium antagonist) and A23187 (an intracellular calcium agonist) could not significantly affect the NE-induced IP 3 production. TMB-8 inhibits Ca 2+ influx from plasma membrane and IP 3 -induced Ca 2+ release from sarcoplasmic reticulum (SR). 9) A23187 selectively acts on voltage-dependent Ca 2+ channels, resulting in elevation of the intracellular calcium concentration. NE-induced IP 3 production is regulated by extracellular Ca 2+ , but not by intracellular Ca 2+ in atrial myocytes. These results support the finding that ANP released by elevation of extracellular Ca 2+ is associated with elevation of NE-induced IP 3 production.
1) However, ANP release by elevation of intracellular Ca 2+ appears to involve a different pathway from that of NE-induced IP 3 production.
We investigated whether PMA (a PKC agonist) or staurosporine (a PKC antagonist) affect NE-induced IP 3 formation. NE activated PKC and the treatment with PMA inhibited NE-induced IP 3 formation and the treatment with staurosporine stimulated NE-induced IP 3 formation, indicating that there is feedback regulation of PKC to IP 3 . Langendorff perfusion in guinea pig hearts with PMA causes an impairment of contraction of the left ventricle and the down-regulation by activation of PKC may be associated with a decrease in inositol phosphates. 10) Barr and Watson reported that a PKC inhibitor potentiated agonist-stimulated accumulation of inositol phosphates in astrocytoma cells. 11) They suggested that the inhibitory feedback by PKC may mediate phosphorylation of PLC. Thus, the inhibitory effect of PKC on NE-induced IP 3 formation appears to be associated with both receptor desensitization and down-regulation in atrial myocytes.
The IP 3 -induced Ca 2+ release requires calmodulin-dependent IP 3 receptor phosphorylation.
12) W7 interferes with the binding between the calmodulin receptor and Ca
2+
-calmodulin complex in cardiomyocytes. 13) We found that W7 has a positive effect on NE-induced IP 3 formation. Wolf, et al reported that W7 caused Ca 2+ release from SR and potentiated IP 3 -induced Ca 2+ mobilization. 14) These results indicate that W7 causes Ca 2+ release from SR through elevation of IP 3 . IP 3 is metabolized by a IP 3 -3-kinase to IP 4 . The IP 3 -3-kinase is activated in a calmodulin dependent manner. 15) /CaM-dependent protein kinase and contributes to phosphorylation of myosin light chain. DAG produces PKC, which also plays an important role in phosphorylation of myosin light chains. Extracellular Ca 2+ increases NE-induced IP 3 formation through activation of G-protein via calcium ion sensing receptors. PMA (a PKC agonist) significantly decreased and staurosporine (a PKC antagonist) significantly stimulated NE-induced IP 3 production. W7 (a calmodulin antagonist) significantly increased the NE-induced IP 3 .
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Neonatal myocardium is more sensitive to extracellular calcium concentrations than is adult myocardium. This is related to the poorly developed sarcoplasmic reticulum of neonatal myocardium. 16) It is unclear whether the intracellular changes associated with maturation of the atrial myocytes affect NE-induced IP 3 formation. PMA, staurosporine, TMB-8, and W7 have been used for many years as pharmacologic tools. PMA and staurosporine are known as a PKC agonist and antagonist, respectively. We used 1 and 10 nM PMA and staurosporine for preventing several actions at high concentrations. TMB-8 inhibits the release of intracellularly stored Ca 2+ .
16) Two µM TMB-8 for 15 minutes significantly decreased the concentration of intracellular calcium in atrial muscle. As high concentrations of TMB-8 have several actions, including depression of protein kinase C and tyrosine kinase, 17) the culture was exposed for 30 minutes at a concentration of 1 µM TMB-8 in this study. W-7 has been reported to increase the release from the SR by interfering with the binding between the calmodulin receptor and Ca
2+
-calmodulin complex, 18) but is ineffective as an inhibitor of PKC or protein kinase A. 19) Thus, PMA, staurosporine, TMB-8, or W7 at the concentration used in this study appear to be specific.
In conclusion, elevation of extracellular Ca 2+ concentrations affects NEinduced IP 3 formation in neonatal rat atrial myocytes. PKC and calmodulin are involved in regulation of the IP 3 response to NE.
